Literature DB >> 20802019

Associations of cumulative sun exposure and phenotypic characteristics with histologic solar elastosis.

Nancy E Thomas1, Anne Kricker, Lynn From, Klaus Busam, Robert C Millikan, Mary E Ritchey, Bruce K Armstrong, Julia Lee-Taylor, Loraine D Marrett, Hoda Anton-Culver, Roberto Zanetti, Stefano Rosso, Richard P Gallagher, Terence Dwyer, Chris Goumas, Peter A Kanetsky, Colin B Begg, Irene Orlow, Homer Wilcox, Susan Paine, Marianne Berwick.   

Abstract

BACKGROUND: Solar elastosis adjacent to melanomas in histologic sections is regarded as an indicator of sun exposure, although the associations of UV exposure and phenotype with solar elastosis are yet to be fully explored.
METHODS: The study included 2,589 incident primary melanoma patients with assessment of histologic solar elastosis in the population-based Genes, Environment, and Melanoma study. Ambient erythemal UV (UVE) at places of residence and sun exposure hours, including body site-specific exposure, were collected. We examined the association of cumulative site-specific and non-site-specific sun exposure hours and ambient UVE with solar elastosis in multivariable models adjusted for age, sex, center, pigmentary characteristics, nevi, and, where relevant, body site.
RESULTS: Solar elastosis was associated most strongly with site-specific UVE [odds ratio (OR) for top exposure quartile, 5.20; 95% confidence interval (95% CI), 3.40-7.96; P for trend <0.001] and also with site-specific sun exposure (OR for top quartile, 5.12; 95% CI, 3.35-7.83; P for trend <0.001). Older age (OR at >70 years, 7.69; 95% CI, 5.14-11.52; P for trend < 0.001) and having more than 10 back nevi (OR, 0.77; 95% CI, 0.61-0.97; P = 0.03) were independently associated with solar elastosis.
CONCLUSION: Solar elastosis had a strong association with higher site-specific UVE dose, older age, and fewer nevi. IMPACT: Solar elastosis could be a useful biomarker of lifetime site-specific UV. Future research is needed to explore whether age represents more than simple accumulation of sun exposure and to determine why people with more nevi may be less prone to solar elastosis. ©2010 AACR.

Entities:  

Mesh:

Year:  2010        PMID: 20802019      PMCID: PMC2976811          DOI: 10.1158/1055-9965.EPI-10-0686

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  30 in total

1.  Numerically stable algorithm for discrete-ordinate-method radiative transfer in multiple scattering and emitting layered media.

Authors:  K Stamnes; S C Tsay; W Wiscombe; K Jayaweera
Journal:  Appl Opt       Date:  1988-06-15       Impact factor: 1.980

2.  Predicting five-year outcome for patients with cutaneous melanoma in a population-based study.

Authors:  R L Barnhill; J A Fine; G C Roush; M Berwick
Journal:  Cancer       Date:  1996-08-01       Impact factor: 6.860

3.  Measures of cumulative exposure from a standardized sun exposure history questionnaire: a comparison with histologic assessment of solar skin damage.

Authors:  Margaret R Karagas; Michael S Zens; Heather H Nelson; Kiyohiko Mabuchi; Ann E Perry; Therese A Stukel; Leila A Mott; Angeline S Andrew; Katie M Applebaum; Martha Linet
Journal:  Am J Epidemiol       Date:  2007-01-04       Impact factor: 4.897

Review 4.  The role of elastin and collagen in cutaneous aging: intrinsic aging versus photoexposure.

Authors:  Jouni Uitto
Journal:  J Drugs Dermatol       Date:  2008-02       Impact factor: 2.114

5.  Distinct sets of genetic alterations in melanoma.

Authors:  John A Curtin; Jane Fridlyand; Toshiro Kageshita; Hetal N Patel; Klaus J Busam; Heinz Kutzner; Kwang-Hyun Cho; Setsuya Aiba; Eva-Bettina Bröcker; Philip E LeBoit; Dan Pinkel; Boris C Bastian
Journal:  N Engl J Med       Date:  2005-11-17       Impact factor: 91.245

6.  Sun exposure and host phenotype as predictors of cutaneous melanoma associated with neval remnants or dermal elastosis.

Authors:  Eva Y Lee; Richard Williamson; Peter Watt; Maria Celia Hughes; Adèle C Green; David C Whiteman
Journal:  Int J Cancer       Date:  2006-08-01       Impact factor: 7.396

7.  p53 expression and risk factors for cutaneous melanoma: a case-control study.

Authors:  D C Whiteman; P G Parsons; A C Green
Journal:  Int J Cancer       Date:  1998-09-11       Impact factor: 7.396

8.  Associations between silicone skin cast score, cumulative sun exposure, and other factors in the ausimmune study: a multicenter Australian study.

Authors:  Robyn M Lucas; Anne-Louise Ponsonby; Keith Dear; Bruce V Taylor; Terence Dwyer; Anthony J McMichael; Patricia Valery; Ingrid van der Mei; David Williams; Michael P Pender; Caron Chapman; Alan Coulthard; Trevor Kilpatrick
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-10-20       Impact factor: 4.254

9.  Genome-wide association study of tanning phenotype in a population of European ancestry.

Authors:  Hongmei Nan; Peter Kraft; Abrar A Qureshi; Qun Guo; Constance Chen; Susan E Hankinson; Frank B Hu; Gilles Thomas; Robert N Hoover; Stephen Chanock; David J Hunter; Jiali Han
Journal:  J Invest Dermatol       Date:  2009-04-02       Impact factor: 8.551

10.  Solar elastosis in cutaneous melanoma.

Authors:  Robin T Vollmer
Journal:  Am J Clin Pathol       Date:  2007-08       Impact factor: 2.493

View more
  18 in total

1.  Sun exposure and melanoma survival: a GEM study.

Authors:  Marianne Berwick; Anne S Reiner; Susan Paine; Bruce K Armstrong; Anne Kricker; Chris Goumas; Anne E Cust; Nancy E Thomas; Pamela A Groben; Lynn From; Klaus Busam; Irene Orlow; Loraine D Marrett; Richard P Gallagher; Stephen B Gruber; Hoda Anton-Culver; Stefano Rosso; Roberto Zanetti; Peter A Kanetsky; Terry Dwyer; Alison Venn; Julia Lee-Taylor; Colin B Begg
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-07-28       Impact factor: 4.254

2.  Associations of MC1R Genotype and Patient Phenotypes with BRAF and NRAS Mutations in Melanoma.

Authors:  Nancy E Thomas; Sharon N Edmiston; Peter A Kanetsky; Klaus J Busam; Anne Kricker; Bruce K Armstrong; Anne E Cust; Hoda Anton-Culver; Stephen B Gruber; Li Luo; Irene Orlow; Anne S Reiner; Richard P Gallagher; Roberto Zanetti; Stefano Rosso; Lidia Sacchetto; Terence Dwyer; Eloise A Parrish; Honglin Hao; David C Gibbs; Jill S Frank; David W Ollila; Colin B Begg; Marianne Berwick; Kathleen Conway
Journal:  J Invest Dermatol       Date:  2017-08-24       Impact factor: 8.551

3.  A cancer registry-based analysis on the non-white populations reveals a critical role of the female sex in early-onset melanoma.

Authors:  Tze-An Yuan; Frank Meyskens; Feng Liu-Smith
Journal:  Cancer Causes Control       Date:  2018-03-09       Impact factor: 2.506

4.  XPC (A2920C), XPF (T30028C), TP53 (Arg72Pro), and GSTP1 (Ile105Val) polymorphisms in prognosis of cutaneous melanoma.

Authors:  Gabriela Vilas Bôas Gomez; Cristiane de Oliveira; José Augusto Rinck-Junior; Aparecida Machado de Moraes; Gustavo Jacob Lourenço; Carmen Silvia Passos Lima
Journal:  Tumour Biol       Date:  2015-10-02

5.  Association of Interferon Regulatory Factor-4 Polymorphism rs12203592 With Divergent Melanoma Pathways.

Authors:  David C Gibbs; Irene Orlow; Jennifer I Bramson; Peter A Kanetsky; Li Luo; Anne Kricker; Bruce K Armstrong; Hoda Anton-Culver; Stephen B Gruber; Loraine D Marrett; Richard P Gallagher; Roberto Zanetti; Stefano Rosso; Terence Dwyer; Ajay Sharma; Emily La Pilla; Lynn From; Klaus J Busam; Anne E Cust; David W Ollila; Colin B Begg; Marianne Berwick; Nancy E Thomas
Journal:  J Natl Cancer Inst       Date:  2016-02-08       Impact factor: 13.506

6.  Inherited Genetic Variants Associated with Melanoma BRAF/NRAS Subtypes.

Authors:  Nancy E Thomas; Sharon N Edmiston; Irene Orlow; Peter A Kanetsky; Li Luo; David C Gibbs; Eloise A Parrish; Honglin Hao; Klaus J Busam; Bruce K Armstrong; Anne Kricker; Anne E Cust; Hoda Anton-Culver; Stephen B Gruber; Richard P Gallagher; Roberto Zanetti; Stefano Rosso; Lidia Sacchetto; Terence Dwyer; David W Ollila; Colin B Begg; Marianne Berwick; Kathleen Conway
Journal:  J Invest Dermatol       Date:  2018-05-09       Impact factor: 8.551

7.  Imatinib for melanomas harboring mutationally activated or amplified KIT arising on mucosal, acral, and chronically sun-damaged skin.

Authors:  F Stephen Hodi; Christopher L Corless; Anita Giobbie-Hurder; Jonathan A Fletcher; Meijun Zhu; Adrian Marino-Enriquez; Philip Friedlander; Rene Gonzalez; Jeffrey S Weber; Thomas F Gajewski; Steven J O'Day; Kevin B Kim; Donald Lawrence; Keith T Flaherty; Jason J Luke; Frances A Collichio; Marc S Ernstoff; Michael C Heinrich; Carol Beadling; Katherine A Zukotynski; Jeffrey T Yap; Annick D Van den Abbeele; George D Demetri; David E Fisher
Journal:  J Clin Oncol       Date:  2013-06-17       Impact factor: 44.544

8.  Long-term ultraviolet flux, other potential risk factors, and skin cancer risk: a cohort study.

Authors:  Shaowei Wu; Jiali Han; Francine Laden; Abrar A Qureshi
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-06       Impact factor: 4.254

9.  Comparison of clinicopathologic features and survival of histopathologically amelanotic and pigmented melanomas: a population-based study.

Authors:  Nancy E Thomas; Anne Kricker; Weston T Waxweiler; Patrick M Dillon; Klaus J Busman; Lynn From; Pamela A Groben; Bruce K Armstrong; Hoda Anton-Culver; Stephen B Gruber; Loraine D Marrett; Richard P Gallagher; Roberto Zanetti; Stefano Rosso; Terence Dwyer; Alison Venn; Peter A Kanetsky; Irene Orlow; Susan Paine; David W Ollila; Anne S Reiner; Li Luo; Honglin Hao; Jill S Frank; Colin B Begg; Marianne Berwick
Journal:  JAMA Dermatol       Date:  2014-12       Impact factor: 10.282

10.  The interaction between vitamin D receptor polymorphisms and sun exposure around time of diagnosis influences melanoma survival.

Authors:  Irene Orlow; Yang Shi; Peter A Kanetsky; Nancy E Thomas; Li Luo; Sergio Corrales-Guerrero; Anne E Cust; Lidia Sacchetto; Roberto Zanetti; Stefano Rosso; Bruce K Armstrong; Terence Dwyer; Alison Venn; Richard P Gallagher; Stephen B Gruber; Loraine D Marrett; Hoda Anton-Culver; Klaus Busam; Colin B Begg; Marianne Berwick
Journal:  Pigment Cell Melanoma Res       Date:  2017-11-05       Impact factor: 4.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.